Skip to content
Home
Biosector Blog
Home
Biosector Blog
Posts in Japan pharma
by
Stefan Sandström
May 13, 2026
Takeda’s JPY 200 Billion Pivot: Welcome to Takeda’s New Launch Machine
The JPY 200 billion savings target currently dominating Takeda’s internal dialogue isn’t just a number on […]
1
read more
by
Stefan Sandström
March 12, 2025
Rethinking Japan: Is the Era of Relentless Drug Price Cuts Ending?
Is Japan’s Drug Pricing Squeeze Finally Loosening? Japan has long been a high-pressure pricing environment for […]
0
read more